耐药结核病的流行病学、传播、诊断与管理——南非经验教训
耐药结核病威胁结核病控制,非洲负担沉重且社区传播广泛。南非经验显示需同时检测结核与耐药、应对新药耐药、实施全口服短程(6-9个月)治疗,并解决贫困、污名等结构性问题以改善结局。
要点
- 多数高耐药结核负担地区社区传播广泛,获得性耐药驱动流行不再成立。
- 非洲大量耐药结核未被诊断,因缺乏同时检测结核与耐药的工具。
- 新药及再利用药物耐药且无诊断方案,挑战全口服短程(6-9个月)治疗实施。
核心结论
- 耐药结核病威胁结核病控制,非洲疫情失控,需借鉴南非在诊断、治疗、传播干预及社会经济成本缓解方面的经验。
研究设计与样本
- 综述南非耐药结核病流行病学、传播、诊断与管理经验并提出研究优先事项。
主要发现
- 多数高耐药结核负担地区社区传播广泛,获得性耐药驱动流行的观念不再成立。
- 非洲大量耐药结核未被诊断,因缺乏同时检测结核与耐药的工具。
- 新药及再利用药物耐药且诊断方案未可用,挑战全口服短程(6-9个月)治疗实施。
- 贫困、污名和社会困境破坏治疗参与、导致不良结局并降低生活质量。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Drug-resistant tuberculosis (DR-TB) threatens to derail tuberculosis control efforts, particularly in Africa where the disease remains out of control. The dogma that DR-TB epidemics are fueled by unchecked rates of acquired resistance in inadequately treated or non-adherent individuals is no longer valid in most high DR-TB burden settings, where community transmission is now widespread. A large burden of DR-TB in Africa remains undiagnosed due to inadequate access to diagnostic tools that simultaneously detect tuberculosis and screen for resistance. Furthermore, acquisition of drug resistance to new and repurposed drugs, for which diagnostic solutions are not yet available, presents a major challenge for the implementation of novel, all-oral, shortened (6-9 months) treatment. Structural challenges including poverty, stigma, and social distress disrupt engagement in care, promote poor treatment outcomes, and reduce the quality of life for people with DR-TB. We reflect on the lessons learnt from the South African experience in implementing state-of-the-art advances in diagnostic solutions, deploying recent innovations in pharmacotherapeutic approaches for rapid cure, understanding local transmission dynamics and implementing interventions to curtail DR-TB transmission, and in mitigating the catastrophic socioeconomic costs of DR-TB. We also highlight globally relevant and locally responsive research priorities for achieving DR-TB control in South Africa.
引用
- Naidoo K, Perumal R, Cox H, et al. The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis-lessons from the South African experience. Lancet Infect Dis. 2024. PMID: 38527475. doi:10.1016/S1473-3099(24)00144-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。